ALDOSTERONE SYNTHASE INHIBITORS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table

of Contents

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Global Aldosterone Synthase Inhibitors Market, By Drug Type
     • Global Aldosterone Synthase Inhibitors Market, By Drug
     • Global Aldosterone Synthase Inhibitors Market, By Indication
     • Global Aldosterone Synthase Inhibitors Market, By Stage of Development
     • Global Aldosterone Synthase Inhibitors Market, By Gender
     • Global Aldosterone Synthase Inhibitors Market, By End User
     • Global Aldosterone Synthase Inhibitors Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
   • Driver
   • Restraint
   • Opportunity
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
   • Industry Trends
   • Pipeline Analysis
   • Blockade Mapping
   • Chessboard Mapping
   • Company Positioning Analysis
   • Comparative Matrix

4. Global Aldosterone Synthase Inhibitors Market, By Drug Type, 2021 - 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Selective Aldosterone Synthase Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Non-Selective CYP11B Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Aldosterone Synthase Inhibitors Market, By Drug, 2021 - 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Osilodrostat
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Lorundrostat
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Baxdrostat
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Vicadrostat
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Dexfadrostat
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Aldosterone Synthase Inhibitors Market, By Indication, 2021 - 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Cushing’s Syndrome
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Hypertension
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Primary aldosteronism (Conn's syndrome)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Heart Failure
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
       • Heart Failure with Reduced Ejection Fraction (HFrEF)
       • Heart Failure with Preserved Ejection Fraction (HFpEF)
   • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Aldosterone Synthase Inhibitors Market, By Stage of Development, 2021 - 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Preclinical
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Phase I Clinical Trials
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Phase II Clinical Trials
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Phase III Clinical Trials
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Approved or Marketed
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Aldosterone Synthase Inhibitors Market, By Gender, 2021 - 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Male
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Female
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

9. Global Aldosterone Synthase Inhibitors Market, By End User, 2021 - 2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Hospitals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Cardiology Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Nephrology Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Research and Academic Institutes
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
   • Contract Research Organizations (CROs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

10. Global Aldosterone Synthase Inhibitors Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Drug Type, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Stage of Development, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Gender, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2022 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Drug Type, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Stage of Development, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Gender, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2022 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Drug Type, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Stage of Development, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Gender, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2022 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Drug Type, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Stage of Development, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Gender, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2022 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Drug Type, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Stage of Development, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Gender, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2022 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Drug Type, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Stage of Development, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Gender, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2022 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2022 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa

11. Competitive Landscape

    • Mineralys Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • DAMIAN PHARMA AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CORXEL
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • JX09
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Recordati Rare Diseases Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Other Prominent Players
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

13. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Global Aldosterone Synthase Inhibitors Market' - Global forecast to 2033